Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 12, Issue 6, Pages 476-483
Publisher
Springer Nature
Online
2011-08-09
DOI
10.1038/tpj.2011.33
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation of XPD gene with susceptibility to gastric cancer
- (2012) Chuan-Zhen Zhang et al. Chinese Journal of Cancer
- Powerful SNP-Set Analysis for Case-Control Genome-wide Association Studies
- (2010) Michael C. Wu et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis
- (2010) Zheng Jiang et al. BREAST CANCER RESEARCH AND TREATMENT
- Use of chemotherapy for patients with bone and soft-tissue sarcomas
- (2010) R. WESOLOWSKI et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma
- (2010) J. Smida et al. CLINICAL CANCER RESEARCH
- Emerging drugs for high-grade osteosarcoma
- (2010) Claudia Maria Hattinger et al. EXPERT OPINION ON EMERGING DRUGS
- Genome-Wide Association Studies of Cancer
- (2010) Zsofia K. Stadler et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: A Korean population-based study
- (2009) Hee Seung Kim et al. GYNECOLOGIC ONCOLOGY
- Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai
- (2009) Hui Wen et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- VEGF expression as a prognostic marker in osteosarcoma
- (2009) Jyoti Bajpai et al. PEDIATRIC BLOOD & CANCER
- Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes
- (2009) Penelope A. Bradbury et al. Pharmacogenetics and Genomics
- Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
- (2009) D Caronia et al. PHARMACOGENOMICS JOURNAL
- DNA Repair Gene XPD Polymorphisms and Cancer Risk: A Meta-analysis Based on 56 Case-Control Studies
- (2008) F. Wang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of a missense single nucleotide polymorphism, Cys1367Arg of the WRN gene, with the risk of bone and soft tissue sarcomas in Japan
- (2008) Robert Nakayama et al. CANCER SCIENCE
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma
- (2008) James Doecke et al. INTERNATIONAL JOURNAL OF CANCER
- Relationship BetweenERCC1Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer
- (2008) Thomas C. Krivak et al. JOURNAL OF CLINICAL ONCOLOGY
- Susceptibility of XRCC3, XPD, and XPG Genetic Variants to Cervical Carcinoma
- (2008) Xiaohong He et al. PATHOBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search